Skip to main content

Advertisement

Log in

Depression, Purpose in Life, Loneliness and Anxiety Among Patients with Substance Use Disorders in Ankaful Psychiatric Hospital in Ghana

  • Original Article
  • Published:
Journal of Psychosocial Rehabilitation and Mental Health Aims and scope Submit manuscript

Abstract

Substance use disorders are prevalent worldwide and may lead to a wide range of physical, psychological and emotional health problems in Ghana. There has been an increase in the use of illicit drugs in the past decade. The present study examined the relationships among depression, purpose in life (PIL), loneliness and anxiety with patients diagnosed with substance use disorders (SUDs) in Ankaful Psychiatric Hospital in Ghana. This descriptive and correlational design was conducted among 200 patients using socio-demographic data, Beck Depression Inventory-II, PIL, Revised University of California Los Angeles Loneliness Scale (R-UCLA) and beck anxiety inventory. Data were collected from April 15 to May 30, 2019 and were analyzed using spearman partial correlations, one-way ANOVA, Kruskal–Wallis ANOVA and hierarchical regression. A total of 192 participants completed the survey instruments. The results revealed that purpose in life had a significant negative relationship with depression and anxiety. Depression had a significant direct correlation with anxiety. For loneliness, there was no difference between gender, but a significant finding was found among marital status. For all other dependent variables, purpose in life, depression and anxiety, there were no statistically significant findings. Purpose in life is the only predictor of depression of participants. These findings indicate that patients diagnosed with SUDs have additional psychological and mental health concerns. While treating SUD, mental health professionals should identify and manage those problems too. This may help better management plan for patients with SUD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. DSM-5 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.

    Google Scholar 

  2. Lopez-Quintero C, de Los Cobos JP, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1–2):120–30.

    PubMed  Google Scholar 

  3. Wagner FA, Anthony JC. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26(4):479–88.

    PubMed  Google Scholar 

  4. Poudel A, Sharma C, Gautam S, Poudel A. Psychosocial problems among individuals with substance use disorders in drug rehabilitation centers, Nepal. Subst Abuse Treat Prev Policy. 2016;11(1):28.

    PubMed  PubMed Central  Google Scholar 

  5. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.

    PubMed  Google Scholar 

  6. Ofori-Atta A, Read UM, Lund C, MHaPP Research Programme Consortium. A situation analysis of mental health services and legislation in Ghana: challenges for transformation. Afr J Psychiatry. 2010;13(2):99–108.

    Google Scholar 

  7. Boachie PA. Medical systems in Ghana. Accra: Ghana Publishing; 2005.

    Google Scholar 

  8. Johnson W. Factors influencing drug abuse among student clients of Ankaful psychiatric hospital in the Cape Coast Metropolis. Doctoral dissertation, University of Cape Coast; 2012.

  9. Out-Patient Monthly Morbidity Returns. Psychiatric Unit: Regional Hospital, Sunyani; 2016.

  10. Bryant KJ, Rounsaville B, Spitzer RL, Williams JB. Reliability of dual diagnosis: substance dependence and psychiatric disorders. J Ment Nerv Disord. 1992;180(4):251–7.

    Google Scholar 

  11. El-Guebaly N. Substance use disorders and mental illness: the relevance of comorbidity. Can J Psychiat. 1995;40(1):2–3.

    Google Scholar 

  12. Smith J, Hucker S. Schizophrenia and substance abuse. Br J Psychiatry. 1994;165(1):13–21.

    PubMed  Google Scholar 

  13. Weiss RD, Mirin SM, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict. 1992;87(2):179–87.

    PubMed  Google Scholar 

  14. Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115–29.

    PubMed  Google Scholar 

  15. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.

    PubMed  PubMed Central  Google Scholar 

  16. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. J Am Med Assoc. 1990;264(19):2511–8.

    Google Scholar 

  17. Yilmaz O, Dilbaz N. Complex comorbidity of substance use disorders with anxiety disorders: diagnosis and treatment. New Dev Anxiety Disord. 2016;2016:89–107.

    Google Scholar 

  18. Mueser KT, Rosenberg SD, Drake RE, Miles KM, Wolford G, Vidaver R, Carrieri K. Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. J Stud Alcohol. 1999;60(2):278–84.

    PubMed  Google Scholar 

  19. Kaplan HI, Sadock BJ, Grebb JA. Synopsis of psychiatry. Philadelphia: Williams & Wilkins; 1994. p. 383–456.

    Google Scholar 

  20. Oyefeso A, Ghodse H, Clancy C, Corkefy JM. Suicide among drug addicts in the United Kingdom. Br J Psychiatry. 1999;175(3):277–82.

    PubMed  Google Scholar 

  21. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43–51.

    PubMed  Google Scholar 

  22. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990;147(6):685–95.

    PubMed  Google Scholar 

  23. Carpentier PJ, Krabbe PF, Van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18(6):470–80.

    PubMed  Google Scholar 

  24. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375–80.

    PubMed  Google Scholar 

  25. Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow- up. J Affect Disord. 2009;115(1–2):27–35.

    PubMed  Google Scholar 

  26. Galaif ER, Sussman S, Newcomb MD, Locke TF. Suicidality, depression, and alcohol use among adolescents: a review of empirical findings. Int J Adolesc Med Health. 2007;19(1):27–36.

    PubMed  PubMed Central  Google Scholar 

  27. Åkerlind I, Hörnquist JO. Loneliness and alcohol abuse: a review of evidences of an interplay. Soc Sci Med. 1992;34(4):405–14.

    PubMed  Google Scholar 

  28. Clinebell HJ Jr. Philosophical-religious factors in the etiology and treatment of alcoholism. Q J Stud Alcohol. 1963;24(3):473–88.

    PubMed  Google Scholar 

  29. Kurtz E. Not-God: a history of alcoholics anonymous center city. New York: Hazelden Educational Services; 1979.

    Google Scholar 

  30. Crumbaugh JC, Maholick LT. Manual of instructions for the purpose in life Test. Munster: Psychometrics Affiliates; 1969.

    Google Scholar 

  31. Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996.

    Google Scholar 

  32. Russell D, Peplau LA, Cutrona CE. The revised UCLA loneliness scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980;39(3):472–80.

    PubMed  Google Scholar 

  33. Frankl VE. The doctor and the soul. New York: Vintage; 1959.

    Google Scholar 

  34. Cutrona CE. Nonpsychotic postpartum depression: a review of recent research. Clin Psychol Rev. 1982;2(4):487–503.

    Google Scholar 

  35. Kim O, Byeon YS, Kim JH, Endo E, Akahoshi M, Ogasawara H. Loneliness, depression and health status of the institutionalized elderly in Korea and Japan. Asian Nurs Res. 2009;3(2):63–70.

    Google Scholar 

  36. Hedayati MM, Khazaei MM. An investigation of the relationship between depression, meaning in life and adult hope. Proc Soc Behav Sci. 2014;114:598–601.

    Google Scholar 

  37. Steger MF, Mann JR, Michels P, Cooper TC. Meaning in life, anxiety, depression, and general health among smoking cessation patients. J Psychosom Res. 2009;67(4):353–8.

    PubMed  Google Scholar 

  38. Buchanan DM. Meaning-in-life, depression and suicide in older adults: a comparative survey study. Diss Abstr Int. 1994;54:4075.

    Google Scholar 

  39. Reker GT, Peacock EJ, Wong PT. Meaning and purpose in life and well-being: a life-span perspective. J Gerontol. 1987;42(1):44–9.

    PubMed  Google Scholar 

  40. Steger MF, Frazier P. Meaning in life: one link in the chain from religiousness to well-being. J Couns Psychol. 2005;52(4):574–82.

    Google Scholar 

  41. Zika S, Chamberlain K. On the relation meaning in life and psychological well-being. Br J Psychol. 1992;83(1):133–45.

    PubMed  Google Scholar 

  42. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.

    PubMed  Google Scholar 

  43. Cannon MF, Weems CF. Do anxiety and depression cluster into distinct groups? A test of tripartite model predictions in a community sample of youth. Depress Anxiety. 2006;23(8):453–60. https://doi.org/10.1002/da.20215.

    Article  PubMed  Google Scholar 

  44. Jacobson NC, Newman MG. Avoidance mediates the relationship between anxiety and depression over a decade later. J Anxiety Disord. 2014;28(5):437–45. https://doi.org/10.1016/j.janxdis.2014.03.007.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Norton S, Cosco T, Doyle F, Done J, Sacker A. The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res. 2013;74(1):74–81. https://doi.org/10.1016/j.jpsychores.2012.10.010.

    Article  PubMed  Google Scholar 

  46. De Jong Gierveld J, Van Tilburg T. The De Jong Gierveld short scales for emotional and social loneliness: tested on data from 7 countries in the UN generations and gender surveys. Eur J Ageing. 2010;7(2):121–30.

    PubMed  PubMed Central  Google Scholar 

  47. Nolen-Hoeksema S, Hilt LM. Gender differences in depression. In: Gotlib IH, Hammen CL, editors. Handbook of depression. 2nd ed. New York, NY: Guilford Press; 2009. p. 386–404.

    Google Scholar 

  48. Ryff CD, Singer BH. The contours of positive human health. Psychol Inq. 1998;9(1):1–28.

    Google Scholar 

  49. Cacioppo JT, Hughes ME, Waite LJ, Hawkley LC, Thisted RA. Loneliness as a specific risk factor for depressive symptoms: cross-sectional and longitudinal analysis. Psychol Aging. 2006;21(1):140–51.

    PubMed  Google Scholar 

  50. Springer RMB, Weaver AJ, Linderblatt RC, Naditch RB, Newman RA, Siritsky RN, VandeCreek L. Spirituality, depression, and loneliness among Jewish seniors residing in New York City. J Pastor Care Couns. 2003;57(3):305–18.

    Google Scholar 

  51. EMCDDA. Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Luxembourg: Office for Official Publications of the European Union; 2016. Retrieved from https://www.emcdda.europa.eu/topics/pods/comorbidity-substance-usemental-disorders-europe.

  52. Langås A-M, Malt UF, Opjordsmoen S. Comorbid mental disorders in substance users from a single catchment area—a clinical study. Biomed Central Psychiatry. 2011;11(1):25.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the Directorate of Research, Innovation and Consultancy, University of Cape Coast for funding the study (Grant No. RSG/GRP/CES/2018/10). The authors appreciate the study institution, Ankaful Psychiatric hospital and the study participants, for their cooperation in providing all necessary information.

Author information

Authors and Affiliations

Authors

Contributions

AN conceived the study and was involved in the study design, reviewed the article, analysis, report writing and drafted the manuscript. JN was involved in the study design, analysis and drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Anthony K. Nkyi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nkyi, A.K., Ninnoni, J.P.K. Depression, Purpose in Life, Loneliness and Anxiety Among Patients with Substance Use Disorders in Ankaful Psychiatric Hospital in Ghana. J. Psychosoc. Rehabil. Ment. Health 7, 263–271 (2020). https://doi.org/10.1007/s40737-020-00190-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40737-020-00190-9

Keywords

Navigation